Peter Pisters / LinkedIn
Jul 3, 2025, 18:26
Peter Pisters on The Cancer Letter Podcast: A Bold Vision for Pediatric Cancer Becomes Reality
MD Anderson Cancer Center recently reposted from Peters Pisters on LinkedIn.
”From the day Peter Pisters became president of UT MD Anderson nearly seven years ago, he wanted to do something “really big for pediatric cancer.” Listen to him talk to The Cancer Letter about how that dream is becoming a reality with the launch of Kinder Children’s Cancer Center.
Peter Pisters on LinkedIn:
‘As a sarcoma surgeon at UT MD Anderson Cancer Center, I often looked out the window at Texas Children’s Hospital and thought of the possibilities for collaborating to create a pediatric oncology center. After years of hearing that this was impossible, I am thrilled about our joint venture to launch Kinder Children’s Cancer Center and am proud of what we at MD Anderson are building with Debbie Sukin and her team at Texas Children’s, and I enjoyed talking with The Cancer Letter about it.’ ”
To read the full article and listen to the podcast follow the link.
The Cancer Letter welcomed Dr. Peter Pisters, president of MD Anderson Cancer Center, to discuss the “really big things” being done for pediatric cancer.
In the interview, Dr. Pisters shares a proud moment as he speaks about the joint initiative to launch the Kinder Children’s Cancer Center—now becoming a reality.
Also, he takes a moment to mention building some great things with Debbie Sukin and her team at Texas Children’s Hospital.
Not so impossible after all!
https://cancerletter.com/podcastc/20260701-pisters/
To read more winner stories in the field of hematology, stay tuned with Hemostasis Today.
-
Jun 3, 2026, 17:18Giacomo Rossi: Cysteine and Gut Health – MIT Finds the Switch
-
Jun 3, 2026, 17:00Amin Ullah: Presence of RBCs of Unequal Sizes in a Peripheral Blood Smear – Anisocytosis of RBC
-
Jun 3, 2026, 16:59Jean Connors: Discussing Cancer-Associated Thrombosis at the Japanese Society of Thrombosis and Hemostasis
-
Jun 3, 2026, 16:54Ayush Bhowmik: Failed Drug Became the World’s Most Widely Used Blood Thinner
-
Jun 3, 2026, 16:13Salvador Payán Pernía: Arguing against a Significant Role for Erythropoietin Analogues in the Management of PRCA
-
Jun 3, 2026, 16:08Pedro Henrique Las Casas: How Anticoagulant Agents and Quercetin Influence Cancer Cell Procoagulant Activity
-
Jun 3, 2026, 16:07Suraj Wilson: Back From ASCO 2026 With A Renewed Commitment To Cancer Research
-
Jun 3, 2026, 16:06Kerin A. Da Cruz: MSTU Team Is Creating The Future of Stroke Care In the Northeast Florida
-
Jun 3, 2026, 16:06Andrew Lee: Examining Rare Clotting Disorders After Adenovirus-Based COVID-19 Vaccination